EPIDEMIOLOGICAL PROFILE AND FETO-MATERNAL OUTCOME OF TWIN PREGNANCY: A PROSPECTIVE OBSERVATIONAL STUDY
Ansa Islam1, Iram Sarwar1, Azmat Ali Shah2
1Department of Gynaecology, Ayub Medical College, Abbottabad-Pakistan.
Journal of Ayub Medical College, Abbottabad : JAMC
|November 25, 2024
Summary
Twin pregnancies often lead to preterm birth, maternal anemia, and neonatal intensive care unit (NICU) admissions. However, delivery method and booking status did not significantly impact outcomes, highlighting the need for personalized care.
Area of Science:
- Obstetrics and Gynecology
- Perinatology
- Maternal-Fetal Medicine
Background:
- Twin pregnancies present unique challenges and risks for both mothers and infants.
- Understanding specific maternal and fetal outcomes is vital for clinical practice.
- Identifying influencing factors can improve management strategies for twin gestations.
Purpose of the Study:
- To investigate the maternal and fetal outcomes in twin pregnancies.
- To analyze factors influencing these outcomes, including maternal age and delivery mode.
Main Methods:
- A prospective observational study followed women with twin pregnancies beyond 28 weeks gestation.
- Outcomes were assessed up to 7 days postpartum and analyzed against patient parameters.
- Statistical analysis was performed using SPSS V 26, adhering to ethical guidelines.
Main Results:
- Of 22,922 deliveries, 195 were twin pregnancies, predominantly in women aged 20-29.
- High rates of preterm delivery (59.6%), maternal anemia (54%), and NICU admissions (45.45%) were observed.
- No significant differences in feto-maternal outcomes were linked to delivery mode or booking status.
Conclusions:
- Twin pregnancies are linked to increased risks of preterm birth, maternal anemia, and NICU admissions.
- Delivery method and booking status did not significantly alter feto-maternal outcomes.
- Individualized patient care is crucial for optimizing management of twin pregnancies.
Related Concept Videos
Teratogenicity
2.4K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.4K
Ovarian Cycle
1.0K
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
1.0K


